Relenza® Singapore Clinic

Relenza® Singapore Clinic: Relenza® (zanamivir) clinic, Singapore. For the prevention/prophylaxis and treatment of flu/influenza. Definitions, references, and latest news.

Description

For Flu Treatment
  for adults and children >5 years of age:
  Administer 2 inhalations, twice daily, for 5 days
For Flu Prevention (prophylaxis)
  for adults and juveniles >12 years of age:
  Administer 2 inhalations, once daily, for 10 days

References

• Relenza - Wikipedia, the free encyclopedia
• Relenza: Definition from Answers.com
• Relenza - definition of Relenza in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia.
• Neuraminidase inhibitor - Wikipedia, the free encyclopedia
• Relenza® (zanamivir) package insert

Oseltamivir/zanamivir: Development of resistance in influenza A H1N1 virus infection: case report
Sun, 25 Jul 2010 05:33:33 +0100 | Reactions
(Source: Reactions)

Enabling the Intestinal Absorption of Highly Polar Antiviral Agents: Ion-Pair Facilitated Membrane Permeation of Zanamivir Heptyl Ester and Guanidino Oseltamivir
Sun, 11 Jul 2010 13:58:49 +0100 | Molecular Pharmaceutics
Molecular Pharmaceutics, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable). (Source: Molecular Pharmaceutics)

Flu Vaccines, pharma fraud, quack science, the CDC and WHO -- all exposed by Richard Gale and Gary Null
Fri, 02 Jul 2010 07:00:00 +0100 | NaturalNews.com
(NaturalNews) A remarkable article was published today by authors Richard Gale and Dr. Gary Null of the Progressive Radio Network (http://www.progressiveradionetwork.com). It may be the most shocking (and important) public health article published in the last two years. If you read just one health article this entire month, make it this one.The article is remarkable not just for its timeliness on the issue of mandatory vaccinations and public health policy, but also for its damning evidence that exposes the fraud and quackery of the vaccine industry (as well as the corruption at the CDC and WHO).As you'll read below, flu vaccines remain a mainstay modern medicine only because they provide a reliable source of profits for the pharmaceutical industry which now virtually dictates public healt...

Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
Thu, 01 Jul 2010 23:00:00 +0100 | Antiviral Research
Authors: Hurt AC, Lowther S, Middleton D, Barr IG Using an in vivo ferret model, we investigated the development of resistance to oseltamivir and zanamivir for two different influenza A(H5N1) viruses (A/Vietnam/1203/2004, haemagglutinin phylogenetic clade 1, and A/Chicken/Laos/26/2006, haemagglutinin phylogenetic clade 2.3) by treating the animals with doses equivalent either to the recommended human treatment dose or a range of sub-optimal drug doses. No resistance was observed in oseltamivir-treated ferrets, but analysis of nasal washes from zanamivir-treated ferrets infected with influenza A/Vietnam/1203/2004 revealed one viral isolate (from a ferret receiving the highest dose of zanamivir, 1.0mg/kg twice daily) with a zanamivir IC(50) that was 350-fold higher than the other isolate...

FDA: Termination of Declarations of Emergency Justifying Emergency Use Authorization (EUA) of Certain Antiviral Drugs - Zanamivir, Oseltamivir Phosphate, and Peramivir
Wed, 23 Jun 2010 11:06:48 +0100 | Drugs.com - Pharma News
ROCKVILLE, Md., June 23, 2010--The FDA has posted on its web site letters that announce the termination of  declarations for the emergency use antiviral drugs Zanamivir, Oseltamivir Phosphate, and Peramivir.  The declarations described will... (Source: Drugs.com - Pharma News)

Biotechnological production and applications of N-acetyl-D: -neuraminic acid: current state and perspectives.
Mon, 07 Jun 2010 23:00:00 +0100 | Applied Microbiology and Biotechnology
Authors: Tao F, Zhang Y, Ma C, Xu P N-Acetyl-D: -neuraminic acid (Neu5Ac) and its derivates are a very important group of biomolecules because these sugars occupy the terminal positions in numerous macromolecules, such as the glycans of glycoproteins, and are involved in many biological and pathological phenomena. The synthesis and applications of Neu5Ac are attracting much interest due to the potential applications of this compound in the pharmaceutical industry, such as in the synthesis of the anti-flu drug zanamivir. In this review article, we discuss existing knowledge on the biotechnological production and applications of Neu5Ac and also propose some guidelines for future studies. PMID: 20532754 [PubMed - as supplied by publisher] (Source: Applied Microbiology and Biotechnolog...

BMJ Report Questions WHO Advisors' Ties To Pharmaceutical Industry
Mon, 07 Jun 2010 08:00:00 +0100 | Health News from Medical News Today
"Key scientists behind World Health Organization advice on stockpiling of pandemic flu drugs had financial ties with companies which stood to profit," according to a joint investigation by BMJ in collaboration with the Bureau of Investigative Journalism, BBC News reports (6/4). The investigation revealed that WHO guidance on the use of antiviral drugs and vaccines "issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza," the Guardian reports... (Source: Health News from Medical News Today)

Swine flu experts linked to big pharma
Thu, 03 Jun 2010 23:34:00 +0100 | Guardian Unlimited Science
Trio of scientists who urged stockpiling had previously been paid, says reportScientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit, according to a report out today.An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza.City analysts say that pharmaceutical companies banked more than $7bn (£4.8bn) as governments stockpiled drugs. The issue of transparency has risen to...

Fatal Respiratory Events Caused by Zanamivir Nebulization
Wed, 02 Jun 2010 21:17:45 +0100 | Clinical Infectious Diseases Latest Issue
Clinical Infectious Diseases, Volume 51, Issue 1, Page 121, 1 July 2010. (Source: Clinical Infectious Diseases Latest Issue)